Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2006 Dec;16(12):2619-21.
doi: 10.1007/s00330-006-0495-8. Epub 2006 Oct 24.

Nephrogenic systemic fibrosis: A serious late adverse reaction to gadodiamide

Henrik S Thomsen
Editorial

Nephrogenic systemic fibrosis: A serious late adverse reaction to gadodiamide

Henrik S Thomsen. Eur Radiol. 2006 Dec.
No abstract available

PubMed Disclaimer

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1681/ASN.2006060601', 'is_inner': False, 'url': 'https://doi.org/10.1681/asn.2006060601'}, {'type': 'PubMed', 'value': '16885403', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16885403/'}]}
    2. Marckmann P, Skov L, Rossen K et al (2006) Nephrogenic systemic fibrosis: suspected etiological role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17:2359–2362 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1093/ndt/gfk062', 'is_inner': False, 'url': 'https://doi.org/10.1093/ndt/gfk062'}, {'type': 'PubMed', 'value': '16431890', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16431890/'}]}
    2. Grobner T (2006) Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104–1108 - PubMed
    1. Cowper SE (2001–2006) Nephrogenic fibrosing demopathy [NFD/NSF website]. Available at http://www.icnfdr.org. Accessed 27 Aug 2006
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/j.semarthrit.2005.08.002', 'is_inner': False, 'url': 'https://doi.org/10.1016/j.semarthrit.2005.08.002'}, {'type': 'PMC', 'value': 'PMC1434722', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1434722/'}, {'type': 'PubMed', 'value': '16461069', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16461069/'}]}
    2. Mendoza FA, Artlett CM, Sandorfi N, Latinis K, Piera-Velazquez S, Jimenez SA (2006) Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum 35:238–249 - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1093/ndt/gfg506', 'is_inner': False, 'url': 'https://doi.org/10.1093/ndt/gfg506'}, {'type': 'PubMed', 'value': '14736976', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/14736976/'}]}
    2. Evenepoel P, Zeegers M, Segaert S et al (2004) Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure. Nephrol Dial Transplant 49:469–473 - PubMed

Publication types

MeSH terms